Roflupram exerts neuroprotection via activation of CREB/PGC‐1α signalling in experimental models of Parkinson's disease-Reference-Cited by-同舟云学术

Roflupram exerts neuroprotection via activation of CREB/PGC‐1α signalling in experimental models of Parkinson's disease

Author:

Zhong Jiahong¹²,Dong Wenli¹²,Qin Yunyun¹²,Xie Jinfeng¹²,Xiao Jiao¹²,Xu Jiangping¹²³⁴⁵,Wang Haitao¹²⁴⁵^ORCID

Affiliation:

1. Department of Neuropharmacology and Drug Discovery, School of Pharmaceutical Sciences Southern Medical University Guangzhou China

2. Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences Southern Medical University Guangzhou China

3. Central Laboratory Southern Medical University Guangzhou China

4. Key Laboratory of Mental Health of the Ministry of Education Southern Medical University Guangzhou China

5. Center for Brain Science and Brain‐Inspired Intelligence, Guangdong‐Hong Kong‐Macao Greater Bay Area Southern Medical University Guangzhou China

Funder

Guangzhou Science, Technology and Innovation Commission

Water Resources Department of Guangdong Province

Ministry of Education of the People's Republic of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology

Link

Reference54 articles.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献